Strategic Acquisition Opportunity: Biotechnology Intellectual Property of Civetta Therapeutics, LLC Now Open for Bids
The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company's rich portfolio of intellectual property.
- The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company's rich portfolio of intellectual property.
- The available intellectual property portfolio offers a unique opportunity to invest in a cutting-edge area of biotechnology.
- This is a rare opportunity to acquire a comprehensive portfolio of intellectual property in a field with immense therapeutic and commercial potential.
- Interested parties are invited to submit their bids for Civetta Therapeutics' intellectual property by April 30, 2024, 5:00 PM Central Time.